Libo Yang

Extracting pharmaceuticals from water using metal–organic frameworks

ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models

In Vitro Assays of Breast Cancer Stem Cells

Risk factors for pancreatic cancer: a summary review of meta-analytical studies

Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

ANRIL: A lncRNA at the CDKN2A/B Locus With Roles in Cancer and Metabolic Disease

Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy

Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes

Gene regulation by long non-coding RNAs and its biological functions

Vapochromic Luminescence of a Zirconium‐Based Metal–Organic Framework for Sensing Applications

Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells

Metal–organic frameworks: functional luminescent and photonic materials for sensing applications

Concluding remarks: current and next generation MOFs

An Ultrastable Europium(III)–Organic Framework with the Capacity of Discriminating Fe²⁺/Fe³⁺ Ions in Various Solutions

Metal–Organic Frameworks for the Removal of Emerging Organic Contaminants in Water

Chronic Hepatitis B Virus Infection and Risk of Pancreatic Cancer: A Meta-analysis

A luminescent cadmium(ii) metal–organic framework based on a triazolate–carboxylate ligand exhibiting selective gas adsorption and guest-dependent photoluminescence properties

Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/ Smad signaling pathway

The Presence of EpCAM^-/CD49f⁺Cells in Breast Cancer Is Associated with a Poor Clinical Outcome

Synthesis, crystal structure and photocatalytic properties of a Mn (II) metal-organic framework based on a thiophene-functionalized dicarboxylate ligand

Evaluation of the Chinese herbal medicine Jinlida in type 2 diabetes patients based on stratification: Results of subgroup analysis from a 12‐week trial